Burnett Patrick 4
4 · Arcutis Biotherapeutics, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Burnett Patrick
See Remarks
Transactions
- Sale
Common Stock
2025-12-31$28.81/sh−541$15,586→ 97,766 total - Sale
Common Stock
2025-12-31$29.39/sh−1,156$33,974→ 96,610 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted on August 3, 2020.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.08 to $29.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $29.0829 to $29.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.